Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

Although the currently available antidepressants are well established in the treatment of the major depressive disorder (MDD), there is strong variability in the response of individual patients. Reliable predictors to guide treatment decisions before or in an early stage of treatment are needed. DNA...

Full description

Bibliographic Details
Main Authors: Braus, D.F (Author), Cetin, M. (Author), Dahmen, N. (Author), Engelmann, J. (Author), Foo, J.C (Author), Frank, J. (Author), Gasparoni, G. (Author), Herzog, D.P (Author), Lieb, K. (Author), Müller, M.B (Author), Riemenschneider, M. (Author), Rietschel, M. (Author), Sirignano, L. (Author), Sordon, S. (Author), Spaniol, C. (Author), Streit, F. (Author), Tadic, A. (Author), Wagner, S. (Author), Witt, S.H (Author), Zillich, L. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items